Viewing Study NCT00673335


Ignite Creation Date: 2025-12-24 @ 10:19 PM
Ignite Modification Date: 2026-05-29 @ 4:30 AM
Study NCT ID: NCT00673335
Status: COMPLETED
Last Update Posted: 2024-07-01
First Post: 2008-05-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation
Sponsor: UNICANCER
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None brca1 Mutation Carrier View
None brca2 Mutation Carrier View
None Breast Cancer View
None Hereditary Breast/Ovarian Cancer (brca1, brca2) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None hereditary breast/ovarian cancer (BRCA1, BRCA2) View
None BRCA1 mutation carrier View
None BRCA2 mutation carrier View